Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999

Sexually Transmitted Infections

Volumn 78, Issue 4, 2002, Pages 255-260

  Del Amo, Julia ^a   Del Romero, J ^b   Barrasa, A ^c   Perez Hoyos S ^d   Rodriguez C ^b   Diez M ^c   Garcia S ^b   Soriano, V ^e   Castilla, J ^a,c   Sánchez, Flor ^f   Dona, Carmen ^e   Benito, José Miguel ^e   Peña, José María ^e   Dronda, Fernando ^g   Roca, Victor ^h   Santos, Ignacio ⁱ   Cosín, Jaime ^j   Górgolas, Miguel ^k   Rubio, Rafael ^l   Barros, Carlos ^m   Gómez, Javier ⁿ   Sanz, José ^o   Martín, Teodoro ^p   Ballesteos, Juan ^q   more..

^a MINISTERIO DE SANIDAD Y CONSUMO   (Spain)

^b CENTRO SANITARIO SANDOVAL   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Escuela Valenciana Estudios en Salud   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f CARLOS III INSTITUTE OF HEALTH   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^k HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^l HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^m HOSPITAL DE MÓSTOLES   (Spain)

ⁿ HOSPITAL SEVERO OCHOA   (Spain)

^o HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^p HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^q CSS   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEROCONVERSION; SPAIN;

EID: 0036045310     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.78.4.255     Document Type: Article

References (31)

1. Of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study
2. Declining morbidity and mortality among patients with advanced HIV infection
3. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
4. Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment. Italian HIV Seroconversion Study
5. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: Comparison of cohort studies with randomized trials
6. Multicenter AIDS Cohort Study. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis
7. Survival after introduction of HAART in people with known duration of HIV infection
8. Distinguishing efficacy, individual effectiveness and population effectiveness of therapies
9. Impact of human immunodeficiency virus infection on mortality among young men and women in Spain
10. Vigilancia epidemiológica de la infección por VIH/sida en la comunidad de Madrid. Situación a 31 de diciembre de 2000
11. AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort
12. El periodo de incubación del SIDA en España antes de la terapia HAART
13. The AIDS incubation period in the UK estimated from a national register of HIV seroconverters
14. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: Results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study
15. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
16. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis
17. The UK Register of HIV Seroconverters: Methods and analytical issues
18. How complete is AIDS surveillance in Europe? An eagle eye comparison with mortality data
19. Exhaustividad del registro de casos de sida de la comunidad de Madrid, 1990-1995
20. Estimating the completeness of AIDS reporting in Spain
21. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
22. Risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study
23. Impact of socioeconomic status on survival with AIDS
24. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care
25. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy
26. More rapid progression to AIDS in older HIV-infected people: The role of CD4+ T-cell counts
27. The practical significance of potential biases in estimates of the AIDS incubation periods distribution in the UK Register of HIV Seroconverteres
28. Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS
29. Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid